Researchers from Cellendes showcase, for the first time, the light-inducible hydrogel technology as a product to be launched, at the “3D Cell Culture 2025 – Functional Precision Medicine” conference in Freiburg from April 08-10.
The “3D Cell Culture 2025 – Functional Precision Medicine” Conference focused on the application areas of functional precision medicine addressing questions related on how 3D cell culture technologies, organoids, cellular aggregates and microphysiological systems could improve patient outcomes and treatments of serious diseases such as cancer, diabetes, cystic fibrosis and complex gastrointestinal diseases, such as Crohn’s disease and ulcerative colitis. Additionally, the researchers also discussed about the potential use of these technologies in the research and treatment of allergies, wound healing disorders, neurodegenerative diseases and development of more efficient blood brain barrier models.
In addition to the scientific presentations in talks and posters, an extensive company exhibition space integrated in the conference offered a unique opportunity to promote technologies, products and services in the 3D cell culture field, completing the conference program.
In this context Christine Blechschmidt and Brigitte Angres from Cellendes presented the new light-inducible hydrogel technology in a stand at the 8th 3D Cell Culture conference in Freiburg, which was very well received. For the first time this product was presented to the research community in a demo where visitors could observe the hydrogel forming under a 395 nm LED lamp. The stand was well attended and researchers got great insight into what scientists would like to do with the hydrogel once available on the market.
The conference provided an excellent opportunity for exchange and networking, contributing to the dissemination of the B-BRIGHTER project and its new 3D bioprinting technology.